Navigation Links
Fluorescent markers to distinguish Trypanosoma brucei strains causing Sleeping Sickness

Multiple-genotype infections are increasingly recognized as important factors in disease evolution, parasite transmission dynamics, and the evolution of drug resistance. However, the distinction of co-infecting site genotypes and the tracking of their dynamics have been // ficult with traditional methods based on various genotyping techniques, leaving most questions unaddressed.

Trypanosoma brucei , a protozoan parasite transmitted by the bite of the tsetse fly (Glossina spp.), is of great medical and economic interest in Africa. It causes human sleeping sickness, and Nagana, a cattle disease that prevents cattle farming and the use of work animals over huge areas of sub-Saharan Africa, thus profoundly affecting the economics of the entire continent.

A recent study, to be published in Acta Tropica (available online 4 October 2005) reports new fluorescence markers of various colours that are inserted into the genome of T. brucei to phenotypically label live parasites of all life cycle stages. If different parasite strains are labelled with different colours they can be easily distinguished from each other in experimental studies.

For the study, a total of 10 T. brucei strains were successfully transfected with different fluorescence markers and were monitored in culture, tsetse flies and mice, to demonstrate stability of marker _expression.

The use of fluorescence activated cell sorting (FACS) allowed rapid and accurate identification of parasite strains labelled with different markers. Cell counts by FACS were virtually identical to counts by traditional microscopy but were considerably faster and had a significantly lower sampling error . Co-infecting strains transfected with fluorescence genes of different colour were easily distinguished by eye and their relative and absolute densities were reliably counted by FACS in experimental multiple infections in mice.

Since the FACS can simultaneously determine th e population sizes of differently labelled T. brucei strains or subspecies it allows detailed and efficient tracking of multiple-genotype infections within a single host or vector individual, enabling more powerful studies on parasite dynamics. In addition, it also provides a simple way to separate genotypes after experimental mixed infections, to measure responses of the single strains to an applied treatment, thus eliminating the need for laborious cloning steps.

The markers presented in this study broaden the spectrum of tools available for experimental studies on multiple-genotype infections. They are fundamentally different from isoenzyme analysis and other genotyping approaches in that they allow the distinction of parasite genotypes based on an easily recognizable phenotypic trait.

The authors conclude that the distinction of live parasites based on an easily recognized phenotypic trait and the physical separation of genotypes from mixed infections made possible by live fluorescence markers make trypanosomes an attractive system for experimental studies on parasite population dynamics. The marker described in this study will be especially important by opening new avenues of research on the ecology and evolution of mixed trypanosome infections and their implications for disease dynamics and control. The authors assert that they will be of specific interest to researches addressing ecological, evolutionary and epidemiological questions using trypanosomes as an experimental system.
'"/>




Related medicine news :

1. Scientific markers of aging described
2. Molecular markers for early diagnosis of breast and ovarian cancer
3. Biomarkers May Indicate Alzheimers Disease
4. Biomarkers Could Prove Significant In Understanding Aging Process
5. Researchers Find Mix of Biomarkers Predicting Mortality
6. Biomarkers Predicting Mortality Found Using Statistical Technique
7. Biomarkers Found Harmful For Human Lupus
8. Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread
9. Biomarkers Ability to Predict Heart Disease and Stroke is Limited
10. Probable Biomarkers for Squamous Cell Carcinoma
11. New Genetic Biomarkers Could Predict Coronary Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic Trainers from ... Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, evidence based ... Trainers are acknowledged by their peers with accolades and highly prestigious awards. This ...
(Date:9/20/2017)... ... 2017 , ... Medicare doesn’t have the authority to negotiate ... their prescription drugs, according to a new comparison of drug plans by ... there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare policy ...
(Date:9/20/2017)... ... 20, 2017 , ... “Finn Mouseson”: follows the exciting story of a mouse ... mouse sets out on a journey that will show that friends are to be ... newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s degree in ...
(Date:9/20/2017)... ... ... “The Financial Favor of God; Second Edition”: a personal and exquisite recipe for ... of published author, Brooks Rathell. , “We typically hear about the favor of God. ... favor of God. Not only does it exist, but it is meant for you. ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a ... leader, Denise Flannery, to its strategic advisory and client development team. , ... work with clients across different industries to develop and implement market-justified strategies, modernize ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... N.J. , Sept. 1, 2017  Bayer will present ... the European Society for Medical Oncology (ESMO) 2017 Congress, September ... presented will include new preclinical and clinical data on Bayer,s ... two earlier pipeline projects. ... the best minds in cancer research at ESMO," said ...
(Date:8/29/2017)... -- ivWatch, LLC, the leading provider of continuous monitoring devices for ... awarded an Innovative Technology contract from Vizient, Inc., the largest member-driven ... ... early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ivWatch based ...
(Date:8/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will present at the ... in New York . John Greisch ... present at 11:05 a.m. Eastern Time. The ... A recorded replay will be available one hour after the ... About Hill-Rom Holdings, Inc. ...
Breaking Medicine Technology: